Arthrocare Corporation

Type: Company
Name: Arthrocare Corporation
First reported 2 hours ago - Updated 2 hours ago - 1 reports

Smith & Nephew share price rises on upbeat Q2 statement

iNVEZZ.com, Friday, August 1: Shares in Smith & Nephew Plc (LON:SN) have advanced more than one percent in London after the artificial hips and knees maker revealed that its trading profit had surged in the second quarter.As of 09:57 BST, Smith & Nephew’s ... [Published Invezz - 2 hours ago]
First reported 6 hours ago - Updated 4 hours ago - 2 reports

Smith & Nephew Ups Dividend, Reiterates Confidence In Outlook

at 05:07 AM EDT LONDON (Alliance News) - Smith & Nephew PLC Friday raised its interim dividend and reiterated confidence in its outlook for the full year, even though pretax profit declined in the second quarter to June 28 due to costs related to its ... [Published Industrial Info Financials - 4 hours ago]
First reported 7 hours ago - Updated 6 hours ago - 1 reports

Smith & Nephew 2014 Q2 Results

Smith & Nephew plc (LSE: SN, NYSE: SNN) results for the second quarter ended 28 June 2014. An analyst presentation and conference call to discuss Smith & Nephew's second quarter results will be held at 9.00am BST/4.00am EST today, Friday 1 August. This ... [Published Noodls - 7 hours ago]
First reported 6 hours ago - Updated 6 hours ago - 1 reports

Smith & Nephew H1 pretax profit marginally lower

StockMarketWire.com - Smith & Nephew booked an H1 pretax profit of $349m, from $392m. Revenue totalled $2,220m, from $2,149m. In the second quarter, pretax profit was $188m, from $128m. CEO Olivier Bohuon said Sith & Nephew had delivered a good increase ... [Published Stock Market Wire - 6 hours ago]
First reported Jul 29 2014 - Updated Jul 29 2014 - 1 reports

Arthrocare Shares Up 33.8% Since SmarTrend's Buy Recommendation (ARTC)

Written on Mon, 07/28/2014 - 6:29pmBy James QuinnSmarTrend identified an Uptrend for Arthrocare ( NASDAQ:ARTC ) on November 25th, 2013 at $36.33. In approximately 8 months, Arthrocare has returned 33.77% as of today's recent price of $48.60.Over the ... [Published Comtex SmarTrend - Jul 29 2014]
First reported Jul 21 2014 - Updated Jul 21 2014 - 1 reports

Arthrocare Up 33.8% Since SmarTrend Uptrend Call (ARTC)

Written on Mon, 07/21/2014 - 12:51pmBy Nick RussoSmarTrend identified an Uptrend for Arthrocare ( NASDAQ:ARTC ) on November 25th, 2013 at $36.33. In approximately 8 months, Arthrocare has returned 33.77% as of today's recent price of $48.60.Arthrocare ... [Published Comtex SmarTrend - Jul 21 2014]
First reported Jul 14 2014 - Updated Jul 14 2014 - 1 reports

33.8% Return Seen to Date on SmarTrend Arthrocare Call (ARTC)

SmarTrend identified an Uptrend for Arthrocare (NASDAQ:ARTC) on November 25th, 2013 at $36.33. In approximately 8 months, Arthrocare has returned 33.77% as of today's recent price of $48.6 ... [Published Individual.com - Jul 14 2014]
First reported Jul 14 2014 - Updated Jul 14 2014 - 1 reports

Guidant loses bid to drop breach-of-contract in JNJ lawsuit | Medtech legal news for the week of July 14, 2014

Here's a look at some of the top legal news stories for medical device companies this week: Guidant can't slip breach-of-contract charges in Johnson & Johnson suit; Biomet reveals SEC subpoena over alleged 'improprieties' in Brazil, Mexico; Appeals court ... [Published MassDevice - Jul 14 2014]
First reported Jul 07 2014 - Updated Jul 08 2014 - 4 reports

Board suspends ex-PricewaterhouseCoopers accountant over ArthroCare scandal

by The Public Accounting Oversight Board suspends ex-PricewaterhouseCoopers accountant Randall Stone for failing to address a $400 million fraud scheme at ArthroCareThe fallout over a $400 million fraud scheme by former ArthroCare  (NSDQ: ARTC ) executives ... [Published MassDevice - Jul 08 2014]
First reported Jul 03 2014 - Updated Jul 03 2014 - 1 reports

Judge denies former Arthrocare executives' motions for acquittal in fraud case

A Texas federal judge has refused to acquit ArthroCare Corp.'s former CEO and chief financial officer on charges that they allegedly perpetrated a $400 million fraud by inflating the medical company's earnings, according to court documents.In an order ... [Published Business First of Buffalo - Jul 03 2014]
First reported Jul 03 2014 - Updated Jul 03 2014 - 2 reports

ArthroCare Corporation (ARTC) - Product Pipeline Analysis, 2014 Update

Albany, NY -- (SBWIRE) -- 07/03/2014 -- ArthroCare Corporation (ArthroCare) is a multi-business medical device company. It develops, manufactures and markets minimally invasive surgical products, which are based on the patented Coblation technology. The ... [Published The CW11 - Jul 03 2014]
First reported Jul 03 2014 - Updated Jul 03 2014 - 1 reports

Convictions stand for ex-ArthroCare execs in $400M fraud scheme

by The a federal judge declines to overturn the convictions of former ArthroCare CEO Michael Baker and CFO Michael Gluk in a $400 million scheme to defraud investors.A federal jury yesterday refused to overturn the convictions of 2 former ArthroCare ... [Published MassDevice - Jul 03 2014]

Quotes

...It said the Vito's share of the new London licensed taxi market fell to 24%, from 44% a year earlier. "Trading has remained challenging mainly due to uncertainty caused in the London licensed taxi trade by the emergence of Uber as well as the Mayor of London's proposed introduction of zero emissions standards from 2018" the company said
"With half of our revenues now coming from higher growth markets, and a more focused structure, we are well placed to take advantage of the many further opportunities we see" Bohuon said in a statement
Looking ahead, Smith & Nephew said in its statement, "We anticipate that the prevailing market conditions seen in the first half of 2014 will continue throughout the rest of the year. We expect the Established Markets to be broadly stable with some signs of improvement, and the increasingly important Emerging & International Markets to continue to offer good opportunities for stronger growth."
" and similar expressions are generally intended to identify forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause actual results to differ materially from what is expressed or implied by the statements. For Smith & Nephew, these factors include: economic and financial conditions in the markets we serve, especially those affecting health care providers, payers and customers; price levels for established and innovative medical devices; developments in medical technology; regulatory approvals, reimbursement decisions or other government actions; product defects or recalls; litigation relating to patent or other claims; legal compliance risks and related investigative, remedial or enforcement actions; strategic actions, including acquisitions and dispositions, our success in performing due diligence, valuing and integrating acquired businesses; disruption that may result from transactions or other changes we make in our business plans or organisation to adapt to market developments; and numerous other matters that affect us or our markets, including those of a political, economic, business, competitive or reputational nature. Please refer to the documents that Smith & Nephew has filed with the U S Securities and Exchange Commission under the U S Securities Exchange Act of 1934, as amended, including Smith & Nephew's most recent annual report on Form 20-F, for a discussion of certain of these factors. Any forward-looking statement is based on information available to Smith & Nephew as of the date of the statement. All written or oral forward-looking statements attributable to Smith & Nephew are qualified by this caution. Smith & Nephew does not undertake any obligation to update or revise any forward-looking statement to reflect any change in circumstances or in Smith & Nephew's expectations. ◊ Trademark of Smith & Nephew. Certain marks registered US Patent and Trademark Office."

More Content

All (213) | News (61) | Reports (0) | Blogs (139) | Audio/Video (0) | Fact Sheets (0) | Press Releases (13)
sort by: Date | Relevance
Smith & Nephew share price rises on upbeat Q2 s... [Published Invezz - 2 hours ago]
UK WINNERS & LOSERS : Smith & Nephew, Rexam Lea... [Published 4 Traders - 3 hours ago]
Smith & Nephew Ups Dividend, Reiterates Confide... [Published Industrial Info Financials - 4 hours ago]
Smith & Nephew : Ups Dividend, Reiterates Confi... [Published 4 Traders - 6 hours ago]
Smith & Nephew Q2 Pretax Profit Down, Revenue R... [Published RTTNews.com - 6 hours ago]
Smith & Nephew H1 pretax profit marginally lower [Published Stock Market Wire - 6 hours ago]
Smith & Nephew 2014 Q2 Results [Published Noodls - 7 hours ago]
Arthrocare Shares Up 33.8% Since SmarTrend's Bu... [Published Comtex SmarTrend - Jul 29 2014]
Minimally Invasive Surgery Market - Global Indu... [Published MyNewsDesk - Jul 28 2014]
Olivier Bohuon puts Smith & Nephew under the knife [Published Telegraph - Jul 27 2014]
July Accounting and Auditing Highlights [Published Bureau of National Affairs - Jul 24 2014]
BUENA VISTA REGIONAL MEDICAL CENTER DISBURSEMENTS [Published Storm Lake Pilot Tribune - Jul 22 2014]
Arthrocare Up 33.8% Since SmarTrend Uptrend Cal... [Published Comtex SmarTrend - Jul 21 2014]
St. Jude Medical Pays $200M for NeuroTherm [Published The Street Latest - Jul 15 2014]
Medtronic, Thermo Fisher Making Largest Medtech... [Published QMED - Jul 15 2014]
Deal frenzy transforming world pharma [Published Ireland Business World - Jul 14 2014]
33.8% Return Seen to Date on SmarTrend Arthroca... [Published Individual.com - Jul 14 2014]
Guidant loses bid to drop breach-of-contract in... [Published MassDevice - Jul 14 2014]
Movers and Shakers July 2014 [Published PM 360 - Jul 11 2014]
Smith and Nephew adds robotic navigation capabi... [Published Zenopa - Jul 11 2014]
This Week In Securities Litigation (Week ending... [Published JD Supra - Jul 11 2014]
INFOGRAPHIC: The changing face of the orthopedi... [Published Clinica - Jul 10 2014]
Board suspends ex-PricewaterhouseCoopers accoun... [Published MassDevice - Jul 08 2014]
PCAOB Bars Ex-PwC Partner for Lax Revenue Audit [Published CFO.com - Jul 07 2014]
PCAOB Disciplines Former PwC Partner for Audit ... [Published WebCPA - Jul 07 2014]
PCAOB Announces Settled Disciplinary Action Aga... [Published PCAOB - Jul 07 2014]
Judge denies former Arthrocare executives' moti... [Published Business First of Buffalo - Jul 03 2014]
Steroid Epidural Injections No Benefit in Spina... [Published Diabetes Care - Jul 03 2014]
ArthroCare Corporation (ARTC) - Product Pipelin... [Published The CW11 - Jul 03 2014]
ArthroCare Corporation (ARTC) - Product Pipelin... [Published SBWire - Jul 03 2014]
1 2 3 4 5 6 7 8
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Research and Markets: Global Sports Medicine De... [Published Business Wire Health News - May 19 2014]
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/5qst5j/sports_medicine) has announced the addition of the "Global Sports Medicine Devices Market - Forecasts to 2019: Major players profiled in this report include ...
Frontrunning: May 5 [Published Zero Hedge - May 05 2014]
Fed’s Fisher Says Economy Strengthening as Payrolls Rise ( BBG ) Russia Knows Europe Sanctions Ineffective With Tax Havens ( BBG ) EU Cuts Euro-Area Growth Outlook as Inflation Seen Slower ( BBG ) U.S. Firms With Irish Addresses Get Tax Breaks Derided ...
ArthroCare Reports First Quarter 2014 Financial... [Published Business Wire Health News - May 02 2014]
AUSTIN, Texas--(BUSINESS WIRE)--ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced its financial results for the quarter ended March 31, 2014. FIRST QUARTER 2014 SUMMARY Total revenue ...
Research and Markets: Mexico Arthroscopy Market... [Published Business Wire Health News - Apr 29 2014]
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/c95drm/mexico) has announced the addition of the "Mexico Arthroscopy Market Outlook to 2020" report to their offering. Our new report, "Mexico Arthroscopy Market ...
Health Care Stocks on our Radar -- Research on ... [Published PR Newswire: Financial Services - Apr 02 2014]
LONDON, April 2, 2014 /PRNewswire/ --On Tuesday, April 1, 2014, the NASDAQ Composite ended at 4,268.04, up 1.64%, the Dow Jones Industrial Average advanced 0.46% to finish at 16,532.61, and the S&P 500 closed at 1,885.52, up 0.70%. The gains were broad ...
1 2 3 4 5 6 7 8 9 10 ...

Press Releases

sort by: Date | Relevance
Pre-market Equity Watch on the Health Care Sect... [Published Financial Services - May 05 2014]
Zacks Industry Outlook Highlights: Zimmer Holdi... [Published Financial Services - May 02 2014]
Pre-Market Health Care Stocks Analysis: Medtron... [Published Financial Services - Mar 13 2014]
Stock Price Updates, Appointment, and Financial... [Published Financial Services - Mar 06 2014]
INVESTOR ALERT - ARTHROCARE CORPORATION: The La... [Published Financial Services - Feb 11 2014]
1 2 3
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.